vs
IRONWOOD PHARMACEUTICALS INC(IRWD)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.6倍($78.6M vs $47.7M),IRONWOOD PHARMACEUTICALS INC净利率更高(-4.8% vs -178.3%,领先173.5%),Repay Holdings Corp同比增速更快(0.4% vs -47.3%),IRONWOOD PHARMACEUTICALS INC自由现金流更多($74.6M vs $23.2M),过去两年Repay Holdings Corp的营收复合增速更高(-1.3% vs -20.2%)
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
IRWD vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.6倍
$47.7M
营收增速更快
RPAY
高出47.7%
-47.3%
净利率更高
IRWD
高出173.5%
-178.3%
自由现金流更多
IRWD
多$51.3M
$23.2M
两年增速更快
RPAY
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $47.7M | $78.6M |
| 净利润 | $-2.3M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 14.3% | -182.2% |
| 净利率 | -4.8% | -178.3% |
| 营收同比 | -47.3% | 0.4% |
| 净利润同比 | -200.9% | -3304.1% |
| 每股收益(稀释后) | $0.01 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRWD
RPAY
| Q4 25 | $47.7M | $78.6M | ||
| Q3 25 | $122.1M | $77.7M | ||
| Q2 25 | $85.2M | $75.6M | ||
| Q1 25 | $41.1M | $77.3M | ||
| Q4 24 | $90.5M | $78.3M | ||
| Q3 24 | $91.6M | $79.1M | ||
| Q2 24 | $94.4M | $74.9M | ||
| Q1 24 | $74.9M | $80.7M |
净利润
IRWD
RPAY
| Q4 25 | $-2.3M | $-140.1M | ||
| Q3 25 | $40.1M | $-6.4M | ||
| Q2 25 | $23.6M | $-102.3M | ||
| Q1 25 | $-37.4M | $-7.9M | ||
| Q4 24 | $2.3M | $-4.1M | ||
| Q3 24 | $3.6M | $3.2M | ||
| Q2 24 | $-860.0K | $-4.1M | ||
| Q1 24 | $-4.2M | $-5.2M |
毛利率
IRWD
RPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
营业利润率
IRWD
RPAY
| Q4 25 | 14.3% | -182.2% | ||
| Q3 25 | 61.8% | -3.9% | ||
| Q2 25 | 53.2% | -138.7% | ||
| Q1 25 | -70.7% | -4.7% | ||
| Q4 24 | 34.8% | -1.5% | ||
| Q3 24 | 28.0% | -0.9% | ||
| Q2 24 | 26.5% | -4.6% | ||
| Q1 24 | 14.7% | -3.1% |
净利率
IRWD
RPAY
| Q4 25 | -4.8% | -178.3% | ||
| Q3 25 | 32.8% | -8.3% | ||
| Q2 25 | 27.7% | -135.2% | ||
| Q1 25 | -90.9% | -10.3% | ||
| Q4 24 | 2.5% | -5.3% | ||
| Q3 24 | 4.0% | 4.1% | ||
| Q2 24 | -0.9% | -5.4% | ||
| Q1 24 | -5.6% | -6.5% |
每股收益(稀释后)
IRWD
RPAY
| Q4 25 | $0.01 | $-1.68 | ||
| Q3 25 | $0.23 | $-0.08 | ||
| Q2 25 | $0.14 | $-1.15 | ||
| Q1 25 | $-0.23 | $-0.09 | ||
| Q4 24 | $0.03 | $-0.04 | ||
| Q3 24 | $0.02 | $0.03 | ||
| Q2 24 | $-0.01 | $-0.04 | ||
| Q1 24 | $-0.03 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $-261.8M | $484.4M |
| 总资产 | $396.9M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
IRWD
RPAY
| Q4 25 | $215.5M | $115.7M | ||
| Q3 25 | $140.4M | $95.7M | ||
| Q2 25 | $92.9M | $162.6M | ||
| Q1 25 | $108.5M | $165.5M | ||
| Q4 24 | $88.6M | $189.5M | ||
| Q3 24 | $88.2M | $168.7M | ||
| Q2 24 | $105.5M | $147.1M | ||
| Q1 24 | $121.5M | $128.3M |
总债务
IRWD
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | $199.5M | $279.5M | ||
| Q2 25 | $199.3M | $279.0M | ||
| Q1 25 | $199.2M | $497.6M | ||
| Q4 24 | $199.0M | $496.8M | ||
| Q3 24 | $198.8M | $496.2M | ||
| Q2 24 | $198.6M | $435.6M | ||
| Q1 24 | $398.3M | $434.9M |
股东权益
IRWD
RPAY
| Q4 25 | $-261.8M | $484.4M | ||
| Q3 25 | $-264.2M | $616.9M | ||
| Q2 25 | $-308.2M | $633.7M | ||
| Q1 25 | $-334.1M | $755.7M | ||
| Q4 24 | $-301.3M | $761.3M | ||
| Q3 24 | $-311.3M | $754.7M | ||
| Q2 24 | $-321.7M | $815.4M | ||
| Q1 24 | $-330.5M | $813.8M |
总资产
IRWD
RPAY
| Q4 25 | $396.9M | $1.2B | ||
| Q3 25 | $396.1M | $1.3B | ||
| Q2 25 | $342.9M | $1.4B | ||
| Q1 25 | $327.2M | $1.5B | ||
| Q4 24 | $350.9M | $1.6B | ||
| Q3 24 | $389.5M | $1.6B | ||
| Q2 24 | $395.6M | $1.5B | ||
| Q1 24 | $438.8M | $1.5B |
负债/权益比
IRWD
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $74.6M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $23.2M |
| 自由现金流率自由现金流/营收 | 156.3% | 29.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $127.0M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
IRWD
RPAY
| Q4 25 | $74.6M | $23.3M | ||
| Q3 25 | $47.6M | $32.2M | ||
| Q2 25 | $-15.1M | $33.1M | ||
| Q1 25 | $20.0M | $2.5M | ||
| Q4 24 | $15.2M | $34.3M | ||
| Q3 24 | $9.9M | $60.1M | ||
| Q2 24 | $33.5M | $31.0M | ||
| Q1 24 | $45.0M | $24.8M |
自由现金流
IRWD
RPAY
| Q4 25 | $74.6M | $23.2M | ||
| Q3 25 | $47.6M | $32.1M | ||
| Q2 25 | $-15.1M | $33.0M | ||
| Q1 25 | $19.9M | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | $9.9M | $59.8M | ||
| Q2 24 | $33.4M | $30.5M | ||
| Q1 24 | $44.9M | $24.7M |
自由现金流率
IRWD
RPAY
| Q4 25 | 156.3% | 29.6% | ||
| Q3 25 | 39.0% | 41.3% | ||
| Q2 25 | -17.7% | 43.6% | ||
| Q1 25 | 48.4% | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | 10.8% | 75.6% | ||
| Q2 24 | 35.4% | 40.7% | ||
| Q1 24 | 60.0% | 30.6% |
资本支出强度
IRWD
RPAY
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率
IRWD
RPAY
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |